Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lietzau

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Nursing|August 1, 1996
Teaching symptom management of HIV/AIDS using algorithmsJ Lietzau
Analytical Biochemistry|January 6, 2001
Fluorometric determination of 2'-beta-fluoro-2',3'-dideoxyadenosine 5'-triphosphate, the active metabolite of a new anti-human immunodeficiency virus drug, in human lymphocytesF Dai, J A Kelley, H Zhang, et al.
Annals of Internal Medicine|August 1, 1991
CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapyR Yarchoan, D J Venzon, J M Pluda, et al.
Lancet (London, England)|July 1, 1995
Treatment of HIV-associated Kaposi's sarcoma with paclitaxelM W Saville, J Lietzau, J M Pluda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapyJ M Pluda, D J Venzon, G Tosato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcomaL Welles, M W Saville, J Lietzau, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Nursing|August 1, 1996
Teaching symptom management of HIV/AIDS using algorithmsJ Lietzau
Analytical Biochemistry|January 6, 2001
Fluorometric determination of 2'-beta-fluoro-2',3'-dideoxyadenosine 5'-triphosphate, the active metabolite of a new anti-human immunodeficiency virus drug, in human lymphocytesF Dai, J A Kelley, H Zhang, et al.
Annals of Internal Medicine|August 1, 1991
CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapyR Yarchoan, D J Venzon, J M Pluda, et al.
Lancet (London, England)|July 1, 1995
Treatment of HIV-associated Kaposi's sarcoma with paclitaxelM W Saville, J Lietzau, J M Pluda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapyJ M Pluda, D J Venzon, G Tosato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcomaL Welles, M W Saville, J Lietzau, et al.
Pageof 1